M778-0200 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-[6-(2,3-dimethylphenoxy)pyrimidin-4-yl]piperidine-4-carboxamide

M778-0200 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-[6-(2,3-dimethylphenoxy)pyrimidin-4-yl]piperidine-4-carboxamide
M778-0200 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-[6-(2,3-dimethylphenoxy)pyrimidin-4-yl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M778-0200
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-[6-(2,3-dimethylphenoxy)pyrimidin-4-yl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M778-0200

Molecular Formula

C26H28N4O4 (C26 H28 N4 O4)

Compound Name

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-[6-(2,3-dimethylphenoxy)pyrimidin-4-yl]piperidine-4-carboxamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-1-[6-(23-dimethylphenoxy)pyrimidin-4-yl]piperidine-4-carboxamide

SMILES

Cc1cccc(Oc2cc(N(CC3)CCC3C(Nc(cc3)cc4c3OCCO4)=O)ncn2)c1C

InChI

InChI=1S/C26H28N4O4/c1-17-4-3-5-21(18(17)2)34-25-15-24(27-16-28-25)30-10-8-19(9-11-30)26(31)29-20-6-7-22-23(14-20)33-13-12-32-22/h3-7,14-16,19H,8-13H2,1-2H3,(H,29,31)

InChI Key

RRUVCLLIIDSEIJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27553816

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

460.53

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.816

Distribution Coefficient, logD

3.816

Water Solubility, LogSw

-3.91

Polar Surface Area

68.613

Acid Dissociation Constant (pKa)

10.77

Base Dissociation Constant (pKb)

2.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

M778-0200 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with M778-0200 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M778-0200?
Check Price and Availability of M778-0200, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M778-0200 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M778-0200
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M778-0200
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M778-0200 available by request